Pathology Laboratory Equipment Market Size & Share 2023 to 2032
Market Size by Product (Equipment, Disposables), by End Use (Diagnostic Centers.
Report ID: GMI6260
|
Published Date: July 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Pratiksha Kamthe
Pathology Laboratory Equipment Market Size
Pathology Laboratory Equipment Market size was valued at USD 33 billion in 2022 and is estimated to account for USD 75 billion by 2032. The market refers to the industry involved in the manufacturing, distribution, and sale of various equipment and instruments used in pathology laboratories for disease analysis, diagnosis, and research.
Pathology Laboratory Equipment Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
This market includes a wide range of products such as microscopes, automated analyzers, sample processing systems, whole slide imaging systems, molecular diagnostic instruments, and cytology equipment. These tools are essential for examining specimens, performing tests, preparing samples, and visualizing diseases at a cellular and molecular level. The market serves hospital laboratories, reference laboratories, research institutions, and diagnostic centers. It is driven by factors such as technological advancements, increasing disease prevalence, research and development activities, and the need for accurate and efficient diagnostic tools.
Technological advancements have revolutionized the field of pathology laboratory equipment, driving its growth and evolution. These advancements have significantly improved accuracy, efficiency, and diagnostic capabilities. For instances, advanced imaging systems, tissue diagnostics, automated analyzers, and molecular diagnostic instruments offer enhanced precision and sensitivity, leading to more accurate test results. Additionally, automation and robotics streamline workflows, reduce human error, and boost productivity.
For instance, Danaher Corporation's Leica Biosystems Bond Rx is an automated staining system specifically designed for immunohistochemistry and in situ hybridization in pathology laboratories. It provides reliable and consistent results, making it an essential tool for precise diagnostic testing and research purposes. Furthermore, the digitization of pathology slides and integration of digital pathology systems have facilitated remote access, collaboration, and telepathology consultations. This advancement not only expedites diagnosis but also enhances the ability to share and analyze digital images.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the pathology laboratory equipment market, leading to increased demand. The need for diagnostic testing and research on the virus drove a surge in demand for pathology laboratory equipment, such as automated analyzers, molecular diagnostic instruments, and sample processing systems. The adoption of digital pathology and remote viewing solutions became crucial for remote consultations and analysis, resulting in increased demand for digital imaging systems. The emphasis on biosafety measures also led to increased demand for biosafety cabinets and personal protective equipment in pathology laboratories.
Furthermore, the pandemic highlighted the importance of robust healthcare infrastructure and future preparedness, leading to investments in advanced pathology laboratory equipment. Therefore, the COVID-19 pandemic had a positive impact on the market, as it drove demand and spurred innovation in the industry.
Pathology Laboratory Equipment Market Trends
The growing burden of chronic diseases worldwide will drive the market value. Chronic diseases, such as cancer, cardiovascular diseases, diabetes, and neurological disorders, are becoming increasingly prevalent worldwide. For instances, 41 million deaths occur due to noncommunicable diseases (NCDs) 41 million people every year, making up approximately 74% of global mortality, according to the World Health Organization (WHO). Among NCDs, cardiovascular diseases are the foremost cause, responsible for 17.9 million annual deaths. Cancers follow closely, resulting in 9.3 million deaths, followed by chronic respiratory diseases with 4.1 million deaths, and diabetes with 2 million deaths, including kidney disease associated with diabetes.
These diseases pose a significant healthcare burden and require accurate diagnosis and monitoring for effective management. Pathology laboratory equipment, including imaging systems, molecular diagnostic tools, and automated analyzers, play a vital role in detecting and characterizing these diseases. Thus, the growing prevalence of chronic diseases fuels the demand for advanced equipment to facilitate timely and accurate diagnosis.
Pathology Laboratory Equipment Market Analysis
The pathology laboratory equipment market by product is categorized into equipment and disposables. The equipment segment is further subdivided into incubators, laminar flow hood, micro manipulation systems, centrifuges, lab air filtration system, scopes, sonicators and homogenizers, autoclaves and sterilizers, spectrophotometer and microarray equipment, and others. The equipment segment garnered USD 21.4 billion revenue size in the year 2022. The equipment segment is a driving force in the market, meeting the demand for advanced equipment driven by rising disease prevalence and the need for accurate diagnostics. Technological advancements, ongoing research, and development, and increasing healthcare expenditure contribute to its growth. The segment's role in improving diagnostic capabilities and enhancing patient care makes it a key driver of market expansion.
Based on end-use, the pathology laboratory equipment market is segmented into diagnostic centers, hospitals, and others. The diagnostic centers segment accounted for over 54% business share in the year 2022 and is anticipated to witness highest growth during the forecast period. The diagnostic centers conduct a high volume of diverse diagnostic tests, requiring advanced equipment for accurate and timely results. Their focus on quality, collaboration, and personalized medicine drives the demand for pathology laboratory equipment. Additionally, the adoption of digital solutions in diagnostic centers further fuels the market growth.
U.S. pathology laboratory equipment market accounted for USD 12.6 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. The U.S. holds a dominant position in the market, driven by its advanced healthcare infrastructure, strong research and development capabilities, high disease burden, technological advancements, favourable reimbursement policies, and the presence of key market players. The U.S. population is experiencing a growing burden of chronic conditions such as cardiovascular disorders, cancer, diabetes, and chronic respiratory diseases.
For instances, according to the Centers for Disease Control and Prevention (CDC), a significant proportion of U.S. citizens, specifically 6 in 10 individuals, live with at least one chronic disease, such as heart disease, stroke, cancer, or diabetes. These diseases require accurate and efficient diagnostic testing for timely treatment and management. Therefore, the rising prevalence of chronic diseases contributes to the demand for advanced pathology laboratory equipment in the U.S. healthcare system.
Pathology Laboratory Equipment Market Share
Some of the eminent market participants operating in the pathology laboratory equipment market include :
These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
Pathology Laboratory Equipment Industry News:
Pathology laboratory equipment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product (USD Million & Units)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →